Pancreatic ductal adenocarcinomas (PDAC) do not typically respond to immunotherapy, which limits treatment options for this cancer. But, reports [s]Health-Canal[/s] a study has found that by priming with a ther apeutic vaccine and a low dose chemotherapy combination prior to surgery, it is possible to convert PDACs into immunogenic cancers that may respond to immunotherapy.
[link url=http://www.healthcanal.com/cancers/52246-a-vaccine-may-cause-pancreatic-cancer-to-respond-to-immunotherapy.html]Full Health-Canal report[/link]
[link url=http://cancerimmunolres.aacrjournals.org/content/early/2014/06/10/2326-6066.CIR-14-0027.abstract?sid=9118aec0-f4fa-4cf3-a49d-00468a7f3343]Cancer Immunology Research abstract[/link]